The pharmaceutical giant had been in talks to buy the cancer drug developer in a transaction that could have valued ...

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in what would be the latest big deal in the red-hot ...

This week, Bobbi Conner talks with Dr. Arasi Maran about breast cancer survivors and heart health. Dr. Maran is an Associate ...

Revolution Medicines shares drop after Merck buyout talks collapse over price. Deal was valued at $28-32B before negotiations ...

WXII 12.COM. OCTOBER IS BREAST CANCER AWARENESS MONTH. ACCORDING TO THE AMERICAN CANCER SOCIETY, OVER 300,000 WOMEN IN THE U.S. ARE PROJECTED TO BE DIAGNOSED WITH THIS INVASIVE FORM OF THE DISEASE ...

TODAY's Al Roker opens up about his new project with Survivornet where he sits down with fellow prostate cancer survivors who share the experiences, misconceptions, and challenges they’ve faced in an ...

Add Yahoo as a preferred source to see more of our stories on Google. October marks Breast Cancer Awareness Month, and across metro Atlanta, the community is stepping up with walks, wellness events, ...

The deal is yet to be finalized and any potential tie-ups are weeks away, according to a report by the Financial Times citing sources familiar with the matter. This comes amid a looming patent cliff ...